Amine oxidase (flavin-containing) And NotN. Hamaue
List of bibliographic references
Number of relevant bibliographic references: 14.Ident. | Authors (with country if any) | Title |
---|---|---|
000299 | Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Shen-Yang Lim [Malaisie] ; Bernard Ravina [États-Unis] ; Klaus Seppi [Autriche] ; Miguel Coelho [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal] | The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Motor Symptoms of Parkinson's Disease |
000326 | Olivier Rascol [France] ; Andres Lozano [Canada] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche] | Milestones in Parkinson's Disease Therapeutics |
000496 | Ouafa Arib [France] ; Pascal Rat [France] ; Robert Molimard [France] ; Abderrahman Chait [Maroc] ; Philippe Faure [France] ; Renaud De Beaurepaire [France] | Electrophysiological characterization of harmane-induced activation of mesolimbic dopamine neurons |
000B26 | Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] | Evidence-based medical review update : Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004 |
000C28 | Peter Riederer [Allemagne] ; Walter Danielczyk [Autriche] ; Edna Grünblatt [Allemagne] | Monoamine oxidase-B inhibition in Alzheimer's disease |
000D70 | Olivier Rascol [France] ; Pierre Payoux [France, Portugal] ; Fabienne Ory [France] ; Joaquim J. Ferreira [France] ; Christine Brefel-Courbon [France] ; Jean-Louis Montastruc [France] | Limitations of current Parkinson's disease therapy. Discussion |
001237 | A. Nicotra [Italie] ; S. H. Parvez [France] | Cell death induced by MPTP, a substrate for monoamine oxidase B |
001573 | C. Gargalidis-Moudanos [France] ; N. Pizzinat ; F. Javoy-Agid ; A. Remaury ; A. Parini | I2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease |
001579 | V. Plante-Bordeneuve [France] ; D. Taussig [France] ; F. Thomas [France] ; G. Said [France] ; N. W. Wood [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; A. E. Harding [Royaume-Uni] | Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease : Evidence for association of a DRD2 allele |
001600 | N. Andreu [France] ; C. Damase-Michel [France] ; J.-M. Senard [France] ; O. Rascol [France] ; J.-L. Montastruc [France] | A dose-ranging study of selegiline in patients with Parkinson's disease : Effect on platelet monoamine oxidase activity |
001658 | P. Damier [France] ; A. Kastner [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease ? |
001705 | L. Lebreton [France] ; O. Curet [France] ; S. Gueddari [France] ; FATHI MAZOUZ [France] ; S. Bernard [France] ; C. Burstein [France] ; R. Milcent [France] | Selective and potent monoamine oxidase type B inhibitors : 2-substituted 5-aryltetrazole derivatives |
001787 | A. Boireau [France] ; P. Dubedat ; F. Bordier ; C. Peny ; J.-M. Miquet ; G. Durand ; M. Meunier ; A. Doble | Riluzole and experimental parkinsonism : antagonism of MPTP-induced decrease in central dopamine levels in mice |
001790 | J. Dow [France] ; F. Piriou ; E. Wolf [France] ; B. D. Dulery [France] ; K. D. Haegele | Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans |
This area was generated with Dilib version V0.6.29. |